Wacker Biotech and XL-protein have successfully completed a feasibility study on the production of PASylated therapeutic proteins using WACKER’s ESETEC® E. coli secretion technology.

Roche has announced that the U.S. Food and Drug Administration (FDA) has approved PerjetaTM (pertuzumab).

Researchers have been awarded over £310,000 to carry out a study that could help revolutionise the way clinicians treat the pain experienced by thousands of people with diabetes.

New research from the University of Copenhagen shows that even slightly higher levels of glucose in the blood noticeably increase the risk of ischemic heart disease. The study involves more than 80,000 people and has just been published in the well-reputed Journal of the American College of Cardiology.

Study shows how to create effective antibiotics that don’t damage hearing.

Researchers at the University of Sheffield have discovered a parasitic mite has caused the Deformed Wing Virus to proliferate in honey bee colonies.

Pregnant women are benefiting from new rapid tests for syphilis in six countries thanks to influential research by the London School of Hygiene & Tropical Medicine.

Thermo Fisher Scientific Inc., the world leader in serving science, has announced that Frost & Sullivan recently named it the company of the year for integrated biobanking solutions.

Lifestyle advice given by doctors to men diagnosed with infertility should be radically overhauled, according to new research.

A new guide entitled 'Top Ten Tips for Gene Silencing & Delivery' is available from AMSBIO. Drawing upon extensive experience of gene silencing techniques the new guide is aimed at assisting research scientists using or planning to use gene knockdown as a method of revealing the function of genes in biological processes.

The focus seminar “Basics and New Developments in Ultrashort Pulse Laser Technology” took place on May 9 during the International Laser Technology Congress AKL’12 in Aachen. The seminar included the presentation of the results of the BMBF-funded PIKOFLAT project under the heading “System and process technology for structuring large surfaces with high-performance picosecond lasers”.

STEMCELL Technologies Inc. has announced its plans to release a series of new products to advance research and translational applications for human pluripotent stem cells.

Researchers at The University of Nottingham have identified three sets of genetic markers that could potentially pave the way for new diagnostic tools for a deadly type of brain tumour that mainly targets children.

Researchers at the University of East Anglia (UEA) have discovered unexpectedly large genetic differences between two similar species of the pathogenic Cryptosporidium parasite.

A coalition of leading funders of biomedical research and patient groups has today issued a joint statement calling on the European Parliament to continue funding research using embryonic stem cells.

New research suggests that drinking three cups of black tea a day, with no milk or sugar, could reduce several risk factors for heart disease.

At ACHEMA 2012, BioDrop Ltd extended the BioDrop family of products, which represents fresh thinking for micro-volume measurement, with the introduction of the BioDrop TOUCH UV/Vis spectrophotometer.

For British autoclave manufacturer Priorclave, export plays a key and increasingly active role to its overall business growth, currently enjoying major success throughout Asia and the Middle East. Recently it was awarded a United Arab Emirates contract to supply 27, compact C40 steam sterilisers from the company’s standard product range.

Roche and Seaside Therapeutics announced that they have entered into a collaboration to develop disease modifying treatments for fragile X syndrome (FXS) and autism spectrum disorders (ASD), both neurodevelopmental disorders for which there are currently no effective pharmacological treatments that address core symptoms.

Scientists have discovered new clues about a potential weapon in the fight against a dangerous superbug which is becoming increasingly resistant to usual forms of treatment.